thrombin concomitantly provokes edema formation by increasing endothelial permeability, and inhibits alveolar edema resolution by blocking Na
INTRODUCTION
new and exciting therapeutic agents for the treatment of ARDS (16) , and coagulation proteases are currently the subject of intense study with respect to a role in ARDS pathogenesis (17) .
Thrombin can directly influence epithelial and endothelial barrier integrity in vitro (18) .
In endothelial cell monolayers, thrombin directly increases endothelial permeability to albumin (19) , by direct activation of thrombin receptors which in turn activate multiple signaling pathways involving Rho kinase (20) and myosin light chain kinase (21) . The effect of thrombin on epithelial barrier integrity is less well studied, however, one study suggests that thrombin can directly decrease the permeability of epithelial cell monolayers of human bronchial epithelial cells, and the A549 human lung epithelial cell line (18) . In contrast, in a live animal model, thrombin increased lung epithelial permeability, and this permeability increase was dependent on the activation of intravascular coagulation (22) .
These thrombin-induced changes in the endothelial, and perhaps epithelial barrier have led several investigators to propose a role for thrombin (and other coagulation factors) as an edemagenic factor in the lung, promoting interstitial and/or alveolar flooding. Indeed, intravascular application of thrombin provokes edema in an isolated guinea pig lung (23) .
However, no studies to date have addressed a potential role for the coagulation proteases in the resolution of pulmonary edema. In this study, we demonstrate that thrombin can indeed impair alveolar fluid clearance. As such, this study adds to the growing body of data implicating this important protease as an integral pathogenic factor in ALI/ARDS.
Some of the results of these studies have been previously reported in the form of a poster discussion presented at the 2005 International Congress of the American Thoracic Society, San
Diego, California, May 20-25, 2005 (24) .
MATERIALS AND METHODS

Lung preparation and handling
Lungs were isolated from healthy adult male rabbits (Charles River, Sulzfeld, Germany) weighing 3.0 ± 0.5 kg, as described previously (25, 26) . Lungs were perfused by re-circulation of Krebs-Henseleit buffer (120 mM NaCl, 4.3 mM KCl, 1.1 mM KH 2 PO 4 , 25 mM NaHCO 3 , 2.4 mM CaCl 2 , 1.3 mM magnesium phosphate, 0.24 % (m/v) glucose and 5 % (m/v) hydroxyethylamylopectin) at a flow-rate of 100 ml/min with a left atrial pressure of 1.6 mm Hg, via catheters inserted into the pulmonary artery and the left atrium exactly as previously described (25) . Lungs were ventilated with room air supplemented with 4.5 % CO 2 to maintain pH of the re-circulating buffer between 7.35 and 7.37. Peak inspiratory pressure was set to 7.5 mm Hg. A frequency of 30 breaths/min and an inspiratory/expiratory ratio of 1:1 with a positive end-expiratory pressure (PEEP) of 2 mm Hg was applied to prevent atelectasis and to maintain constant minute volume during the experiment. Perfusion pressure, ventilation pressure, and the weight of the isolated organ were continuously monitored on-line.
Treatment of lungs
Lungs were allowed to establish steady-state baseline conditions for 30 min, after which lungs were either nebulized with physiological saline (in the case of sham nebulization) or with amiloride or phalloidin oleate in 2.5 % (v/v) dimethyl sulfoxide (DMSO) in physiological saline, yielding a concentration of 10 µM amiloride or 1 µM phalloidin oleate in the epithelial lining fluid (ELF). This first nebulization (duration 5 min) deposited 0.5 ml of fluid into the alveolar space, with a concomitant 0.5 g transient increase in lung weight, attributable to this fluid that was nebulized into the lung (Fig. 1 , dashed boxes). Lungs were allowed to re-establish steadystate baseline conditions for 30 min, after which thrombin (2.5 U/ml) was applied to the perfusate. In some experiments, phalloidin oleate and then thrombin were applied sequentially in the same experiment, as described above. Experiments were conducted either at 37 °C or at 4 °C.
After a 30 min re-equilibration period, radioactive tracers were applied by ultrasonic nebulization of a mixture of 22 clearance were determined exactly as described previously (25) . These experimental protocols are illustrated in Fig. 1 . Immediately after the termination of perfusion, the bronchoalveolar space was lavaged with 30 ml of unlabeled iso-osmolar mannitol. The entire volume was bolus injected into the trachea and immediately re-aspirated gently. The original 30 ml lavage was reinjected into the trachea, and re-aspirated two times (i.e. a total of three injection-aspiration cycles were performed with the same 30 ml lavage fluid). The total lavage time did not exceed 15 s. The mixed BAL fluid that was re-aspirated out of the lungs (recovery 75 -80 % in all experiments) was then centrifuged at 300 g for 10 min to separate the cells from the supernatant.
The sodium concentrations in the perfusate and bronchoalveolar lavage (BAL) fluid were assessed with a highly sensitive ion-selective electrode (Mettler Toledo, Giessen, Germany). This electrode possesses linearity for sodium in the range from 1 × 10 -5 to 1 × 10 3 mM, with < 0.1 % cross sensitivity for other ions. Assuming that the concentration of sodium in the epithelial lining layer corresponds to that in the vascular fluid (in this case, perfusion medium) (27) has been shown previously to be rapid enough to avoid significant additional sodium entry into the alveolar space during the lavage procedure itself (28) . Furthermore, this time-frame is sufficient to allow adequate mixing of ELF with lavage fluid, since when we load fluid into the lung (by nebulization) the fluid volume that we load into the lung is accurately reflected by an increase in the calculated ELF volume, a value that is derived from the BAL fluid, as we have reported previously (26) . The measured sodium concentrations and calculated ELF volumes are reported in Table 1 .
Electrophysiology
To investigate thrombin-and amiloride-induced changes in macroscopic current, we employed the conventional whole-cell patch-clamp technique (29) essentially as described previously (25 Biotinylation of cell-surface proteins of A549 and ATII cells was undertaken as described previously (35) as modified in (25) . Cells were treated exactly as described above for "ouabainsensitive rubidium-uptake assay", and cell extracts were prepared in 50 mM Tris-Cl, 150 mM 
Assessment of endothelial permeability
Capillary filtration coefficients (K f,c ) were measured to assess changes in endothelial permeability. Coefficients were determined isogravimetrically from the slope of the lung weightgain curve induced by a 7.5 mm Hg step elevation of the venous pressure for 10 min, as described previously (25, 36) . These experiments were performed separately from the studies addressing 22 
Statistical treatment of data
Numerical values are given as the mean ± S.D. Intergroup differences were assessed by a factorial analysis of variance with post hoc analysis with Fisher's least significant difference test,
where P values < 0.05 were considered significant.
RESULTS
Thrombin blocks transepithelial active sodium transport in intact lungs
Immediately after sacrifice, the rabbit lungs had a calculated ELF volume of 0.66 ml (Table 1) .
By the time the isolated, perfused and ventilated lungs have achieved steady-state conditions; they acquired and retained an additional 1.75 ml of fluid. The fluid acquisition stabilized at this point, and remained stable over a three-hour period in untreated lungs. Therefore, under steadystate conditions, the isolated, ventilated and perfused rabbit lungs had an ELF volume that was larger than the ELF volume observed in live animals. Most likely, there is a shift of fluid from the vascular and/or interstitial space into the alveolar space, which is an artifact of the lung isolation and perfusion. Thus, although our baseline ELF volumes are high, they remain stable between attainment of steady state conditions, and the conclusion of the measurements in untreated lungs. After attainment of steady-state conditions, two fluid challenges, of 0.5 ml and 1 ml respectively, were sequentially applied by ultrasonic nebulization ( Fig. 1 ) to an isolated, ventilated and perfused rabbit lung. In healthy control lungs, the first challenge caused a transient 0.5 g increase in lung weight, which corresponds to deposition of 0.5 ml of water into the lung ( (Table 1 ). This fluid retention is an artifact of the lung isolation and perfusion. In control lungs maintained at 37 °C, the ELF volume was constant over the course of the experiment at approximately 2.46 ± 0.23 ml (Fig. 2B) . The ELF volume measurements corroborated our lung weight-gain data. When lungs were maintained at 4 °C, the ELF volume increased to 3.97 ± 0.28 ml, indicating an average 1.51 ml increase in ELF volume. This extra fluid was attributable to fluid that was nebulized into the lung, but which could not be cleared, since active transport processes were shut down at 4 °C. In the presence of amiloride, which also blocks active sodium transport and thereby fluid resorption, the ELF volume was also increased, albeit less dramatically, to 3.12 ± 0.12 ml (i.e. a 0.66 ml increase over control conditions).
Similarly, treatment of lungs with thrombin caused a significant 0.84 ml increase in ELF volume (3.3 ± 0.28 ml) in comparison to control lungs. These data indicated that the bulk of the water that collected in the lungs after thrombin administration was located in the alveolar space. Since active sodium transport plays a key role in alveolar fluid clearance, we investigated the effect of thrombin on transepithelial sodium transport in our lung model. processes. This methodology has been described in detail previously (25) . Original clearance curves depicting 22 Na + transit from the alveolar to the vascular compartments in our isolated, ventilated and perfused rabbit lung model are illustrated in Fig. 3 . At 37 °C, 22 Na + clearance is mediated by both active and passive transport processes, while at 4 °C 22 Na + clearance is attributable exclusively to passive transport processes, since active processes are shut down at this temperature (37) . Thus, the fraction of 22 Na + that is cleared from the lungs at 37 °C but not cleared at 4 °C is attributable to active processes. This active transport fraction is represented by the difference between the area above the curves for the warm (37 °C) and cold (4 °C) control lungs. These data are quantified in Fig. 4 . Passive paracellular permeability was unaffected under all experimental conditions ( Fig. 4 ; open bars). Therefore, the differences we observed in the 22 Na + clearance were attributable to perturbations to active sodium transport (Fig. 4 , closed bars).
After application of thrombin or amiloride, 22 Na + clearance from the lung was reduced to 33.75 ± 2.56 % and 32.50 ± 7.56 % of the control values, respectively (P < 0.01 with versus control lungs). Our amiloride data are consistent with the observation that approximately 60 % of the sodium transport channels in rabbit lungs are amiloride-sensitive (38) . Together, these data indicate that the weight-gains and ELF-volume increases of the lung that are elicited by thrombin are most likely attributable to impaired transepithelial active sodium transport, which in turn blocks alveolar fluid clearance.
Our in vitro experiments in cell culture with endocytic inhibitors (see later) suggested that endocytosis played a key role in the thrombin-mediated effects that we observe on transepithelial active sodium transport. Hence, we applied the cell-permeable phalloidin analogue, phalloidin oleate (1 µM in the ELF) in our isolated lung model. This compound potently inhibits endocytosis. Administration of phalloidin oleate prior to administration of thrombin blocked the thrombin-mediated effects on lung weight gain (0.13 ± 0.10 g; Fig. 2A ), ELF volume increase (2.72 ± 0.27 ml; Fig 2B) and on active sodium clearance (Figs 3 and 4) . In the presence of phalloidin oleate, either with or without thrombin treatment, none of these parameters were significantly changed when compared with sham-treated, control lungs. Taken together, these data suggest that thrombin interferes with active transepithelial sodium transport in intact lungs and that this thrombin effect is linked to phalloidin-sensitive endocytic processes.
Two important effector molecules of transepithelial active sodium transport are ENaC (39) and (40), although potassium and other ion channels could also influence this process (41) . It seemed likely that thrombin stimulated the endocytosis of one or more of these effector molecules. To verify and further elaborate on these findings, studies in cultured lung epithelial cells were undertaken.
Effects of thrombin on whole-cell current in A549 and ATII cells
In the whole-cell mode, A549 cells exhibited inward rectifying currents carried by Na + as reported previously (32) . Pre-incubation the cells with thrombin (2.5 U/ml) for 1 h did not change the whole-cell current ( Fig. 5A and B ; n = 5). When the pretreated cells were additionally superfused with amiloride (10 µM), a significant reduction of the inward Na + current to 51 ± 11 % (at -100 mV) and shift of the reversal potential to +41 mV was observed. Application of 10 µM amiloride to control untreated cells caused a similar effect on the inward Na + current. The effect of thrombin on amiloride-sensitive sodium current was also investigated in ATII cells. (Fig. 7C) , while rotenone slightly, although non-significantly (P > 0.05) blocked this thrombin-mediated effect (Fig. 7C) .
Thrombin increases endothelial permeability in intact lungs
In control isolated, ventilated and perfused rabbit lungs maintained at 37 °C, no change in endothelial permeability was observed, as indicated by essentially unchanged capillary filtration (Fig. 8) . Lungs maintained at 4 °C exhibited no perturbations to endothelial permeability over the 120 min time-course (Fig. 8) . Similarly, no changes in K f,c were observed when lungs were treated with amiloride (10 µM). In contrast to these data, thrombin (2.5 U/ml in the perfusate) caused a significant (P < 0.01) increase in the endothelial permeability, increasing the K f,c by 50 %, to 0.0163 ± 0.0014 ml/min/cm H 2 O/g dry weight (Fig. 8) .
DISCUSSION
Coagulation factors, in particular thrombin, have been implicated both as pathogenic (8) and diagnostic (44) factors in ALI/ARDS. Thrombin has been identified as a factor that can promote edema formation either directly, by increasing endothelial permeability for fluids and large solutes (19); or indirectly, by inducing microvascular coagulopathy and DIC (13, 14, 22) . While several studies have correlated elevated pro-coagulant activity of BAL fluids and plasma with the development of ALI/ARDS (9-11), and the ability of thrombin to provoke alveolar edema has been experimentally demonstrated (45) , no study to date has investigated the impact of thrombin on key properties of the alveolar epithelium with respect to its function in the resolution of alveolar edema.
To address this question, we employed an isolated, ventilated and perfused rabbit lung model. This model was attractive for several reasons. It is a blood-free system, and it was therefore possible to explore the effects of thrombin applied to the vascular compartment, in the absence of plasma peptidase inhibitors. Furthermore, any involvement of the coagulation pathway (such as microvascular coagulopathy) in the persistence of alveolar edema in our model was excluded. This model also facilitates online real-time tracing of sodium efflux from the lung.
However, this model is not without its drawbacks, most notably an elevated steady-state ELF volume, reflecting a shift of fluid from the vascular and/or interstitial space into the alveolar space. This is an artifact of the lung isolation and perfusion, perhaps resulting from severing of the lymphatic vessels that would drain excess interstitial fluid. In spite of this, however, we do not believe that this artifact calls into question the validity of the conclusions we draw from our investigations, since measurements were always made after attainment of steady-state conditions, and the thrombin-induced effects yielded significantly elevated ELF volumes in comparison to those of control, untreated lungs. Furthermore, these thrombin-induced effects could be effectively blocked by a variety of interventions, which maintained the baseline ELF volume equivalent to that observed in control, untreated lungs, both in the absence and presence of thrombin.
Our data indicated that thrombin, applied to the vascular space, caused a pronounced increase in both lung weight and ELF volume after a fluid challenge. These increases were not Similarly, in the presence of phalloidin oleate, thrombin had no effect on 86 Rb + uptake by A549 or ATII cells. Thus, our data indicated that thrombin can promote the endocytosis of Na NAD(P)H oxidase)-, but not mitochondrial NADH-dehydrogenase-generated ROS in the thrombin signaling pathway. However, DPI is an unspecific inhibitor of ROS production, since it inhibits non-mitochondrial NAD(P)H oxidases, and, at the concentrations employed in the present study, it can also inhibit production of superoxide and H 2 O 2 by mitochondria, the major source of cellular ROS, probably by inhibiting NADH-ubiquinone oxidoreductase (complex I) (57), together with various nitric oxide synthases (58) . Thus, while we present evidence here that implicates ROS in the thrombin-signaling pathway, their source remains unclear.
Given that ROS can activate PKC (59) , and the demonstrated role for PKC in coupling hypoxia to Na In our isolated lung model, we have observed that the net weight gain by thrombin-treated lungs was in excess of the weight of fluid that we applied to the lungs with fluid challenges. Thus, after thrombin application, additional fluid was able to leak into the extravascular compartments. This would suggest that additional thrombin-mediated perturbations to alveolar-capillary barrier integrity occur. This barrier is formed by two independent barriers: the vascular endothelium, and the alveolar epithelium. We have already documented in this study that thrombin does not perturb the integrity of the alveolar epithelium, since passive flux of small solutes was unchanged, comparing control lungs to those treated with thrombin. In contrast to these data, thrombin treatment did increase the capillary filtration coefficients, and thus vascular permeability. These data are consistent with other studies documenting thrombin-mediated changes to endothelial barrier integrity in vitro (18) . Thrombin can also increase lung epithelial permeability in live animals, however, this permeability increase was dependent on the activation of intravascular coagulation (22) . Since our model is a bloodfree system, coagulation-dependent perturbations to epithelial permeability are unlikely.
However, the development of alveolar edema in the presence of an apparently intact alveolar membrane is well described (62, 63) , perhaps due to the substantially elevated interstitial hydrostatic pressure (64) that results from interstitial fluid loading from the vascular space, which may force fluid across the alveolar epithelium (65) . In our isolated lung model, in the presence of the endocytosis inhibitor phalloidin oleate (which fully maintains active sodium transport, even in the presence of thrombin) a 0.2 g weight-gain by the lungs (paralleled by a ∼0.17 ml ELF volume increase) was still observed after thrombin application. This weight gain could not be attributed to blocked active transepithelial sodium transport. We believe that this additional fluid gain by the lungs resulted from thrombin-induced increased endothelial permeability.
Taken together, our data suggest that the fluid retention that we observe in thrombintreated lungs is probably the sum of two independent processes that occur concurrently. ultrasonic nebulization, 22 Na clearance from the lung was continuously monitored for 60 min.
Prior to application of tracers, lungs received different treatments, indicated in the scheme in or thrombin (2.5 U/ml in 5 ml perfusate; brown) treatment. For the purposes of clarity, standard deviations (which were always less than 2.2 %, with the exception of control lungs and amiloride-treated lungs at 37 °C, which were 3 % and 5 % respectively) have been omitted. However, they are incorporated into the analyses of these data in Fig. 4 . Na transport (closed bars) was quantified from the data in Fig. 3 as described in the Methods section. The active 22 Na transport in untreated lungs maintained at 37 °C was set at 100 %, with the active 22 Na transport in treated lungs expressed relative to this control value. Passive 
